Patients receiving bad news that they have a serious life-threatening illness will ask 'What hope is there for me?' Many feelings surge through the person,...
Biomedical engineers receive $11.5 million to study how white blood cells navigate Posted By: News-Medical in Medical Research News Published: Tuesday,...
Nanoparticles Could Improve Gene Therapy Reuters Health Monday, January 3, 2005 NEW YORK (Reuters Health) - Tiny particles of silica can act as DNA carriers,...
Harm Seen from Vitamin D Deficiency New York Times Syndicate By SCOTT ALLEN GLOBE STAFF Wednesday, December 29, 2004 A growing body of scientific evidence...
Surv Ophthalmol. 2005 Jan-Feb;50(1):61-80. Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in...
Leuk Lymphoma. 2004 Dec;45(12):2365-72. Microenvironmental Interactions and Survival of CLL B-cells. Munk Pedersen I, Reed J. Chronic Lymphocytic Leukemia...
Leuk Lymphoma. 2005 Jan;46(1):49-54. Second neoplasms in chronic lymphocytic leukemia: incidence and pathogenesis with emphasis on the role of different...
Leuk Lymphoma. 2005 Jan;46(1):87-100. Proapoptotic activity of alemtuzumab alone and in combination with rituximab or purine nucleoside analogues in chronic...
Leuk Lymphoma. 2005 Jan;46(1):113-20. Energy transfer efficiency on lymphocytes of leukemia patients measured by fluorescence polarization. Cohen-Kashi M,...
Leuk Lymphoma. 2005 Jan;46(1):133-6. Report of two novel chromosomal translocations in chronic lymphocytic leukemia. Athanasiadou A, Stamatopoulos K,...
Curr Opin Oncol. 2004 Nov;16(6):581-5. Bcl-2 antisense therapy in hematologic malignancies. Chanan-Khan A. Roswell Park Cancer Institute, Buffalo, New York,...
Curr Opin Oncol. 2004 Nov;16(6):581-5. Bcl-2 antisense therapy in hematologic malignancies. Chanan-Khan A. Roswell Park Cancer Institute, Buffalo, New York,...
Hi Scott, I find the articles you send very interesting. Thankyou. But regarding this particular one, do you buy chance know the "average" CD 23 reading of...
Hogryder00@...
Jan 7, 2005 4:07 am
5484
Does anyone know what "orpha drug status" means? Easier for oncologists to get? Thanks for a response if you know. Ann January 06, 2005 08:01 AM US Eastern...
Hi Ann I believe orphan status is when a drug is still in the testing mode. Researchers have some data that it works, but they do not have complete data to...
I didn't know off hand, of course, and I thought this might be pretty darn impossible to find... However, there happens to be at least one paper in PubMed...
The orphan drug status is for drugs for rare diseases (it has an interesting background and was mandated by Congress after lobbying by interested parties). It...
Leuk Lymphoma. 2005 Feb;46(2):197-206. A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with...
7 Jan 2005, 15:00 GMT - GX15-070 is a novel, targeted cancer treatment designed to induce apoptosis (natural cell death) by inhibiting the Bcl-2 family of...
Histone Deacetylase Inhibitors Act Via Death Pathway NEW YORK (Reuters Health) Jan 06 - The selective anti-tumor effect of histone deacetylase inhibitors...
Leuk Lymphoma. 2005 Mar;46(3):421-3. Chromosomal aberrations and CD38 expression in two siblings with B- cell chronic lymphocytic leukemia: A report of two...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
